EntryPoint Capital’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$149K	Buy	+40,996	New	+$149K	0.07%	534
2024 Q2	–	Sell	-10,590	Closed	-$19.4K	–	850
2024 Q1	$19.4K	Buy	+10,590	New	+$19.4K	0.02%	1101